These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21858179)

  • 1. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
    Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
    PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
    PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
    Rothkegel C; Schmidt PM; Atkins DJ; Hoffmann LS; Schmidt HH; Schröder H; Stasch JP
    Mol Pharmacol; 2007 Nov; 72(5):1181-90. PubMed ID: 17715400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS; Keim Y; Stasch JP; Baxter GF
    Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
    Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
    Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step.
    Dai Y; Stuehr DJ
    Br J Pharmacol; 2022 Jun; 179(11):2505-2518. PubMed ID: 33975383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change.
    Pan J; Zhang X; Yuan H; Xu Q; Zhang H; Zhou Y; Huang ZX; Tan X
    Biochim Biophys Acta; 2016 May; 1864(5):488-500. PubMed ID: 26876536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
    Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
    J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
    Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
    Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
    J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.
    Roy B; Mo E; Vernon J; Garthwaite J
    Br J Pharmacol; 2008 Apr; 153(7):1495-504. PubMed ID: 18204474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.
    Sürmeli NB; Müskens FM; Marletta MA
    J Biol Chem; 2015 Jun; 290(25):15570-15580. PubMed ID: 25907555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO- and haem-independent soluble guanylate cyclase activators.
    Schmidt HH; Schmidt PM; Stasch JP
    Handb Exp Pharmacol; 2009; (191):309-39. PubMed ID: 19089335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
    Stasch JP; Schmidt P; Alonso-Alija C; Apeler H; Dembowsky K; Haerter M; Heil M; Minuth T; Perzborn E; Pleiss U; Schramm M; Schroeder W; Schröder H; Stahl E; Steinke W; Wunder F
    Br J Pharmacol; 2002 Jul; 136(5):773-83. PubMed ID: 12086987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat.
    Surmeli NB; Marletta MA
    Chembiochem; 2012 May; 13(7):977-81. PubMed ID: 22474005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Dasgupta A; Bowman L; D'Arsigny CL; Archer SL
    Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.